科兴生物2023年度报告

☐Yes☒No If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) ofthe Securities Exchange Act of1934. ☐Yes☒No Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of1934 during the preceding 12months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to suchfiling requirements for the past 90 days.☒Yes☐No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405of Regulation S-T during thepreceding 12 months (or such shorter period that the registrant was required to submit such files).☒Yes☐No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growthcompany. See definition of “largeaccelerated filer,” “accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Accelerated filer☒ Non-accelerated filer☐Emerging growth company☐ If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant haselected not to use the extendedtransition period for complying with any new or revised financial accounting standards† provided pursuant to Section13(a) of the Exchange Act.☐ † The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its AccountingStandards Codification afterApril 5, 2012. Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internalcontrol over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm thatprepared or issued its audit report.☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included inthe filing reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensationreceived by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐ Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing: U.S. GAAP☒International Financial Reporting Standards as issued by the International Accounting Standards Board☐Other☐ If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected tofollow.☐Item 17☐Item 18 If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).☐Yes☒No (APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the SecuritiesExchange Act of 1934 subsequentto the distribution of securities under a plan confirmed by a court.☐Yes☐No CONTENTS ITEM 1.Identity of Directors, Senior Management and Advisers3ITEM 2.Offer Statistics and Expected Timetable3ITEM 3.Key Information3 ITEM 4.Information on the Company37ITEM 4A.Unresolved Staff Comments54ITEM 5.Operating and Financial Review and Prospects54ITEM 6.Directors, Senior Management and Employees67ITEM 7.Major Shareholders and Related Party Transactions76ITEM 8.Financial Information77ITEM 9.The Offer and Listing82ITEM 10.Additional Information83ITEM 11.Quantitative and Qualitative Disclosures about Market Risk96ITEM 12.Description of Securities other than Equity Securities97 ITEM 13.Defaults, Dividend Arrearages and Delinquencies97ITEM 14.Material Modifications to the Rights of Security Holders and Use of Proceeds97ITEM 15.Controls and Procedures98ITEM 16A.Audit Committee Financial Expert99ITEM 16B.Code of Ethics99ITEM 16C.Principal Accountant Fees and Services99ITEM 16D.Exemptions from the Listing Standards for Audit Committees100ITEM 16E.Purchases of Equity Securities by the Issuer and Affiliated Purchasers100ITEM 16F.Change in Registrant’s Certifying Accountant100ITEM 16G.Corporate Governance100ITEM 16H.Mine Safety Disclosure100ITEM 16I.Disclosure Regarding Foreign Jurisdictions That Prevent Inspections100ITEM 16J.Insider Trading Policies100ITEM 16KCybersecurity100 ITEM 17.Financial Statements102ITEM 18.Financial Statements102ITEM 19.Exhibits102 INTRODUCTIONIn this annual report on Form 20-F, unless otherwise indicated or unless the context otherwise requires, “Sinovac”, “S